Clinical Trials for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Find clinical trials for metastatic castration-resistant prostate cancer (mcrpc). Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

NCT ID: NCT06126731

The PROMIZE trial is a clinical study investigating the combination of certain antibiotics with a medication called enzalutamide for men with advanced prostate cancer that no longer responds to hor...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bellinzona, , Switzerland, London Borough Of Sutton, , United Kingdom

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

NCT ID: NCT06004661

This clinical trial is studying a treatment called lutetium (177Lu) vipivotide tetraxetan for men with a type of prostate cancer known as metastatic castration-resistant prostate cancer (mCRPC). Th...

Recruiting

Phase: PHASE2 Type: interventional Locations: Vandoeuvre Les Nancy, , France, Napoli, , Italy +8 more

Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer

NCT ID: NCT05806814

This clinical trial is studying a new approach to treating advanced prostate cancer, specifically a type called metastatic castration-resistant prostate cancer (mCRPC). Researchers are looking at a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Oklahoma City, Oklahoma, United States, Oklahoma City, Oklahoma, United States

PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA

NCT ID: NCT04015622

This clinical trial is studying a new approach to treating men with metastatic castration-resistant prostate cancer (mCRPC), a type of prostate cancer that has spread and is no longer responding to...

Recruiting

Phase: PHASE2 Type: interventional Locations: London, Ontario, Canada, Toronto, Ontario, Canada +6 more

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

NCT ID: NCT06134232

This clinical trial is studying a treatment for men with a specific type of prostate cancer called metastatic castrate-resistant prostate cancer (mCRPC). The researchers want to see how well a comb...

Not yet recruiting

Phase: PHASE3 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions